<DOC>
	<DOCNO>NCT02698813</DOCNO>
	<brief_summary>The overall goal study evaluate safety exploratory efficacy injectable filler agent compose umbilical cord mesenchymal stem cell hyaluronic acid improvement wrinkle , acne , pit scar .</brief_summary>
	<brief_title>Safety Study Filler Agent Composed Umbilical Cord Mesenchymal Stem Cells Hyaluronic Acid</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female 18 year ; 2 . Have ability understand comply study requirement , provide write informed consent prior procedure ; 3 . Suitable medical history physical examination like follow preoperative laboratory test result : complete blood count , coagulation , biochemistry , electrocardiogram , hepatogram Î²human chorionic gonadotropin ( hCG ) woman childbearing age . 1 . Patients unable undergo surgery liposuction Klein technique severe cardiovascular disease , severe coagulation disorder include thrombophilia pregnancy ; 2 . Have history active dermal disease , inflammation , related disease ; 3 . Had invasive aesthetic treatment surgery history 6 month treatment ; 4 . Had physical chemical aesthetic treatment 1 month study start ; 5 . Have know history allergic reaction like hypersensitivity hyaluronic acid ; 6 . Patients limit understanding procedure poor compliance study followup schedule ; 7 . Pregnant lactating ; 8 . Use drug ; 9 . Patients preoperative result consider inadequate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>